natgillin/translations-raw huggingface dataset:
Agenerase reduced viral loads in children and adolescents, although very few of those who had taken protease inhibitors in the past responded to treatment and there were very few children aged below four years. 
Pri bolnikih z virusom HIV, odpornim na štiri druge zaviralce proteaz, so tisti, ki so jemali kombinacijo zdravila Agenerase in ritonavirja, po štirih tednih pokazali večje znižanje virusne obremenitve kot tisti, ki so še naprej jemali svoje dotedanje zaviralce proteaz: zdravilo Agenerase je znižalo virusno obremenitev pri otrocih in mladostnikih, vendar se je na zdravljenje odzvalo majhno število tistih, ki so v preteklosti že jemali zaviralce proteaz, med njimi pa je bilo zelo majhno število otrok, mlajših od štirih let.
Agenerase boosted with low-dose ritonavir has been compared with other protease inhibitors in 206 adults who had taken protease inhibitors in the past. 
Pri 206 odraslih, ki so v preteklosti že prejemali zaviralce proteaz, so učinkovitost zdravila Agenerase, ojačenega z nizkimi odmerki ritonavirja, primerjali tudi z učinkovitostjo drugih zaviralcev proteaz.
How does Agenerase work? 
Kako zdravilo Agenerase deluje?
If you are an elderly patient (over 65 years of age), you should take Lyrica normally except if you have problems with your kidneys. 
Če ste starejši bolnik (nad 65 let), lahko jemljete zdravilo Lyrica normalno, razen če imate težave z ledvicami.
Do not use this medicine after the expiry date which is stated on the carton or bottle. 
Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali plastenki.
Lyrica should not be used during pregnancy unless clearly necessary (if the benefit to the mother clearly outweighs the potential risk to the foetus). 
Zdravila Lyrica se ne sme uporabljati med nosečnostjo, razen če je nujno potrebno (če koristi za mater jasno prevladajo nad možnim tveganjem za plod).
Date of first authorisation: 06 July 2004 Date of latest renewal: 06 July 2009 
Datum prve odobritve: 6. julij 2004 Datum zadnjega podaljšanja: 6. julij 2009
Lyrica is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment. 
Zdravilo Lyrica ni namenjeno temu, da bi ga jemali samo, temveč ga je vedno treba uporabljati v kombinaciji z drugimi zdravili proti epilepsiji.
Lyrica and certain other medicines may influence each other (interaction). 
Zdravilo Lyrica in določena druga zdravila imajo lahko medsebojno delovanje (interakcije).
* Alanine aminotransferase increased (ALT) and aspartate aminotransferase increased (AST). 
* zvišanje alanin aminotransferaze (ALT) in aspartat aminotransferaze (AST)
Lyrica oral solution contains small amounts of ethanol (alcohol), less than 100 mg/ml. 
Zdravilo Lyrica peroralna raztopina vsebuje majhne količine etanola (alkohol), in sicer manj kot 100 mg/ml.
The body is also marked with a black band. 
Telo je poleg tega označeno s črno črto.
Note: Steps 4-7 may need to be repeated up to three times to obtain the total dose (Table 1). 
Opomba: Korake 4 do 7 morate morda ponoviti do trikrat, da boste prejeli ustrezni celotni odmerek (Pregledica 1).
If you have the impression that the effect of Lyrica is too strong or too weak, talk to your doctor or pharmacist. 
Če imate občutek, da je učinek zdravila Lyrica premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
What Lyrica is and what it is used for 
Kaj je zdravilo Lyrica in za kaj ga uporabljamo
Very common: may affect more than 1 in 10 people Dizziness, drowsiness, headache. 
Zelo pogosti: pojavijo se lahko pri več kot 1 od 10 bolnikov omotica, zaspanost, glavobol
The capsule body is marked with a black band. 
Telo kapsule je označeno s črno črto.
weight x 
masa x
Do not take Lyrica: If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6). 
Ne jemljite zdravila Lyrica: • če ste alergični na pregabalin ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
In table 2 below all adverse reactions, which occurred at an incidence greater than placebo and in more than one patient, are listed by class and frequency (very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). 
V spodnji preglednici 2 so po organskih sistemih in pogostnosti navedeni vsi neželeni učinki, ki so se pojavili pri več kot enem bolniku in z incidenco, večjo kot pri placebu (zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov)).
The safety and efficacy of Lyrica in children below the age of 12 years and in adolescents (12-17 years of age) have not been established. 
Varnost in učinkovitost zdravila Lyrica pri otrocih, starih do 12 let, in pri mladostnikih (12-17 let) nista bili dokazani.
This product contains lactose monohydrate: see the package leaflet for further information. 
To zdravilo vsebuje laktozo monohidrat: za nadaljnje informacije glejte navodilo za uporabo.
Concomitant use with opioids 
Sočasna uporaba z opioidi
Central nervous system influencing medical products Pregabalin may potentiate the effects of ethanol and lorazepam. 
Zdravila, ki vplivajo na osrednji živčni sistem Pregabalin lahko stopnjuje učinke etanola in lorazepama.
Using the oral syringe, first withdraw 5 ml and empty contents of syringe directly into the mouth, then refill the oral syringe with 2.5 ml and empty the remaining contents into the mouth.] 
Z uporabo peroralne brizge najprej odvzemite 5 ml in izpraznite vsebino brizge neposredno v vaša usta, nato napolnite brizgo do 2,5 ml in izpraznite vsebino brizge v usta.]
• Your doctor will tell you to take Lyrica either twice or three times a day. 
• Zdravilo Lyrica morate vzeti dvakrat ali trikrat na dan.
It is important to take your Lyrica capsules regularly at the same time each day. 
Pomembno je, da kapsule Lyrica jemljete redno, vsak dan ob istem času.
These symptoms may occur more commonly or severely if you have been taking Lyrica for a longer period of time. 
Ti znaki se lahko pojavljajo bolj pogosto in z večjo izrazitostjo, če ste zdravilo Lyrica jemali daljši čas.
Pfizer Service Company, Hoge Wei 10, B1930 Zaventem, Belgium 
Izdelovalec: Pfizer Service Company, Hoge Wei 10, B1930 Zaventem, Belgija
The degree of dizziness, sleepiness and decreased concentration may be increased if Lyrica is taken together with medicines containing: 
Omotica, zaspanost ali zmanjšanje sposobnosti koncentracije se lahko stopnjujejo, če zdravilo Lyrica vzamemo skupaj z zdravili, ki vsebujejo:
• Lyrica may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary. 
• Uporaba zdravila Lyrica lahko povzroči zamegljenost ali izgubo vida ali druge spremembe vida, med katerimi so mnoge začasne.
Not required 
Ni potrebno
patients) 
bolnice)
Continue taking Lyrica until your doctor tells you to stop. 
Zdravilo Lyrica jemljite, dokler vam zdravnik ne naroči, da nehajte.
You should take Lyrica in addition to your current treatment. 
Zdravilo Lyrica morate jemati poleg trenutno uporabljanih zdravil.
Lyrica should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor. 
Zdravila Lyrica ne smete uporabljati med nosečnostjo ali dojenjem, razen če vam tako svetuje zdravnik.
[For example, a 150 mg (7.5 ml) dose will require two withdrawals from the bottle to achieve the entire dose. 
[Primer: za odmerek 150 mg (7,5 ml) bosta potrebna dva odvzema iz plastenke, da bi dosegli celoten odmerek.
creatinine serum 
serumu kreatinin
Your doctor will prescribe Lyrica for you to help treat your epilepsy when your current treatment is not controlling your condition. 
Zdravnik bo predpisal zdravilo Lyrica kot pomoč za zdravljenje epilepsije, če zdravila, ki jih trenutno uporabljate, bolezni ne obvladujejo.
Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. 
Bolniki z redkimi prirojenimi motnjami, kot so intoleranca za galaktozo, laponska oblika zmanjšane aktivnosti laktaze ali malabsorpcija glukoze/galaktoze, ne smejo jemati tega zdravila.
What you need to know before you take Lyrica 
Kaj morate vedeti, preden boste vzeli zdravilo Lyrica
Pregabalin oral bioavailability is estimated to be  90% and is independent of dose. 
Ocenjena biološka uporabnost pregabalina po peroralni uporabi je  90 % in ni odvisna od odmerka.
If while taking Lyrica you notice decreased urination, you should tell your doctor as stopping the medicine may improve this. 
Če med jemanjem zdravila Lyrica zasledite zmanjšano izločanje urina, morate to povedati zdravniku, saj se lahko s prenehanjem jemanja zdravila stanje izboljša.
Not required Not required Not required 
Ni potrebno Ni potrebno Ni potrebno
Take your box or bottle of Lyrica capsules with you. 
S seboj vzemite svojo škatlo ali plastenko kapsul Lyrica.
BID = Two divided doses * Total daily dose (mg/day) should be divided as indicated by dose regimen to provide mg/dose Supplementary dose is a single additional dose 
2-krat/dan = dva deljena odmerka * Celotni dnevni odmerek (mg/dan) je treba razdeliti, kot navaja odmerna shema, da dobimo mg/odmerek.
Pregabalin binds to an auxiliary subunit (2- protein) of voltage-gated calcium channels in the central nervous system. 
Pregabalin se veže na pomožno podenoto (beljakovino 2-) napetostno odvisnih kalcijevih kanalčkov v osrednjem živčevju.
Other medicines and Lyrica 
Druga zdravila in zdravilo Lyrica
Oral Solution Pfizer Service Company Hoge Wei 10 
Peroralna raztopina Pfizer Service Company Hoge Wei 10
Repeat steps 2 to 4 as needed to achieve the required dose (Table 3). 
Ponovite korake 2 do 4 po potrebi, dokler ne dosežete potrebnega odmerka (Preglednica 2).
• A small number of people being treated with anti-epileptics such as Lyrica have had thoughts of harming or killing themselves. 
• Pri majhnem številu bolnikov, ki so se zdravili z antiepileptiki, kot je zdravilo Lyrica, so se pojavile misli na samopoškodovanje ali samomor.
Supplementary dose following haemodialysis (mg) 25 (1.25 ml) 
1-krat/dan dodaten odmerek po hemodializi (mg) 25 (1,25 ml)
Peripheral and central neuropathic pain, epilepsy or Generalised Anxiety Disorder: 
Periferna in centralna nevropatska bolečina, epilepsija ali generalizirana anksiozna motnja:
Invert the bottle (with the syringe attached) and fill the syringe with the liquid by pulling the syringe plunger down to just beyond the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (Figure 4). 
Obrnite plastenko (skupaj s pritrjeno brizgo) in napolnite brizgo s tekočino, tako da povlečete bat brizge malo preko oznake, ki ustreza količini v mililitrih (ml), ki vam jo je predpisal zdravnik (Slika 4).
Lyrica is available in eight pack sizes made of PVC with an aluminium foil backing: a 14 capsules pack containing 1 blister strip, a 21 capsules pack containing 1 blister strip, a 56 capsules pack containing 4 blister strips, a 70 capsules pack containing 5 blister strips, a 84 capsules pack containing 4 blister strips, a 100 capsules pack containing 10 blister strips, a 112 capsules pack containing 8 blister strips and 100 x 1 capsules as perforated unit dose blisters. 
Zdravilo Lyrica je na voljo v osmih velikostih pakiranj iz PVC, dno je iz aluminijaste folije: pakiranje s 14 kapsulami v 1 pretisnem omotu, pakiranje z 21 kapsulami v 1 pretisnem omotu, pakiranje s 56 kapsulami v 4 pretisnih omotih, pakiranje s 70 kapsulami v 5 pretisnih omotih, pakiranje s 84 kapsulami v 4 pretisnih omotih, pakiranje s 100 kapsulami v 10 pretisnih omotih, pakiranje s 112 kapsulami v 8 pretisnih omotih in 100 x 1 kapsula v perforiranem enoodmernem pretisnem omotu.
Oral Syringe Withdrawals to Deliver Prescribed Dose of Lyrica 
Odvzemi s peroralno brizgo za dajanje predpisanih odmerkov zdravila Lyrica
Additional reactions reported from postmarketing experience are included in italics in the list below. 
Dodatni neželeni učinki, o katerih so poročali v obdobju trženja, so v spodnji preglednici navedeni v ležeči pisavi.
In the postmarketing experience, there are reports of respiratory failure, coma and deaths in patients taking pregabalin and opioids and/or other central nervous system (CNS) depressant medicinal products. 
V obdobju trženja so poročali o primerih respiratorne insuficience, kome in smrti pri bolnikih, ki so jemali pregabalin in opioide ter/ali druga zdravila, ki zavirajo osrednji živčni sistem.
Lyrica may have minor or moderate influence on the ability to drive and use machines. 
Zdravilo Lyrica ima lahko blag ali zmeren vpliv na sposobnost vožnje in upravljanja strojev.
Do not stop taking Lyrica unless your doctor tells you to. 
Ne prenehajte jemati zdravila Lyrica, razen če vam to naroči zdravnik.
Lyrica may be taken with oral contraceptives. 
Zdravilo Lyrica lahko jemljete s peroralnimi kontraceptivi.
Pfizer Manufacturing Deutschland GmbH, Betriebsstātte Freiburg, Mooswaldallee 1, 79090 Freiburg, Germany. 
Pfizer Manufacturing Deutschland GmbH, Betriebsstātte Freiburg, Mooswaldallee 1, 79090 Freiburg, Nemčija
What Lyrica is and what it is used for What you need to know before you take Lyrica How to take Lyrica 
Kaj je zdravilo Lyrica in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Lyrica Kako jemati zdravilo Lyrica Možni neželeni učinki
In a case-control study of opioid users, those patients who took pregabalin concomitantly with an opioid had an increased risk for opioid-related death compared to opioid use alone (adjusted odds ratio [aOR], 1.68 [95% CI, 1.19 - 2.36]). 
V študiji s kontrolno skupino pri uporabnikih opioidov so pri bolnikih, ki so jemali pregabalin sočasno z opioidom, ugotovili povečano tveganje za smrt, povezano z uporabo opioidov, v primerjavi s samostojno uporabo opioida (prilagojeno razmerje obetov [aOR - adapted Odds Ratio] 1,68 [95 % IZ, 1,19 - 2,36]).
5.1 Pharmacodynamic properties Pharmacotherapeutic group: Anti-epileptics, other anti-epileptics ATC code: N03AX16 
Farmakoterapevtska skupina: antiepileptiki, drugi antiepileptiki, oznaka ATC: N03AX16.
See section 6.6 for information on administration. 
Za navodila o uporabi glejte poglavje 6.6.
Peripheral and central neuropathic pain: Lyrica is used to treat long lasting pain caused by damage to the nerves. 
Periferna in centralna nevropatska bolečina: Zdravilo Lyrica se uporablja za zdravljenje dolgotrajne bolečine, nastale zaradi okvare živcev.
There have been postmarketing reports of congestive heart failure in some patients receiving pregabalin. 
V obdobju trženja so poročali o primerih kongestivnega srčnega popuščanja pri nekaterih bolnikih, ki so dobivali pregabalin.
Warnings and Precautions Talk to your doctor or pharmacist before taking Lyrica. 
Opozorila in previdnostni ukrepi Pred začetkom jemanja zdravila Lyrica se posvetujte z zdravnikom ali farmacevtom.
There are no adequate data from the use of pregabalin in pregnant women. 
Nosečnost O uporabi pregabalina pri nosečnicah ni zadostnih podatkov.
In addition to the daily dose, a supplementary dose should be given immediately following every 4 hour haemodialysis treatment (see Table 1). 
Poleg dnevnega odmerka morajo bolniki takoj po vsaki 4-urni hemodializi dobiti dodaten odmerek (glejte preglednico 1).
The pregabalin safety profile observed in four paediatric studies in patients with partial seizures with or without secondary generalisation (12-week efficacy and safety study in patients 4 to 16 years of age, n=295; 14-day efficacy and safety study in patients 1 month to younger than 4 years of age, n=175; pharmacokinetic and tolerability study, n=65; and 1 year open label follow on safety study, n=54) was similar to that observed in the adult studies of patients with epilepsy. 
Varnostni profil pregabalina, opažen v štirih študijah pri otrocih s parcialnimi napadi s sekundarno generalizacijo ali brez nje (12-tedenska študija učinkovitosti in varnosti pri bolnikih, starih od 4 do 16 let, n = 295; 14-dnevna študija učinkovitosti in varnosti pri bolnikih, starih od 1 meseca do manj kot 4 leta, n = 175; študija farmakokinetike in prenašanja zdravila, n = 65; in enoletna odprta nadaljevalna študija varnosti, n = 54), je bil podoben tistemu v študijah pri odraslih z epilepsijo.
The active substance, pregabalin, is a gamma-aminobutyric acid analogue [(S)-3-(aminomethyl)-5-methylhexanoic acid]. 
Učinkovina pregabalin je analog gama-aminomaslene kisline [(S)-3-(aminometil)-5-metilheksanojska kislina].
For three times a day take Lyrica once in the morning, once in the afternoon and once in the evening, at about the same time each day. 
Če jemljete zdravilo Lyrica trikrat na dan, ga vzemite zjutraj, popoldne in zvečer, in sicer vsak dan ob približno istem času.
In the postmarketing experience, visual adverse reactions have also been reported, including loss of vision, visual blurring or other changes of visual acuity, many of which were transient. 
V obdobju trženja so poročali tudi o neželenih učinkih na vid; vključno z izgubo vida, zamegljenostjo vida ali drugimi spremembami ostrine vida, med katerimi so bile mnoge prehodnega značaja.
Remove air bubbles from the syringe by pushing the plunger up to the appropriate graduation mark. 
Odstranite zračne mehurčke tako, da pritisnete bat nazaj do ustrezne oznake.
Lyrica may cause dizziness and somnolence and therefore may influence the ability to drive or use machines. 
Zdravilo Lyrica lahko povzroči omotico in somnolenco in tako lahko vpliva na sposobnost vožnje in upravljanja strojev.
Lyrica is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. 
Zdravilo Lyrica je indicirano kot dodatno zdravljenje pri odraslih s parcialnimi napadi, s sekundarno generalizacijo ali brez nje.
Results of a 12-week placebo-controlled study of 295 paediatric patients aged 4 to 16 years and a 14-day placebo-controlled study of 175 paediatric patients aged 1 month to younger than 4 years of age performed to evaluate the efficacy and safety of pregabalin as adjunctive therapy for the treatment of partial onset seizures and a 1 year open label safety study in 54 paediatric patients from 3 months to 16 years of age with epilepsy indicate that the adverse events of pyrexia and upper respiratory infections were observed more frequently than in adult studies of patients with epilepsy (see sections 4.2, 4.8 and 5.2). 
Rezultati 12-tedenske s placebom nadzorovane študije pri 295 pediatričnih bolnikih, starih od 4 do 16 let, in 14-dnevne s placebom nadzorovane študije pri 175 pediatričnih bolnikih, starih od 1 meseca do manj kot 4 leta, ki so jo izvedli za ovrednotenje učinkovitosti in varnosti pregabalina kot dodatne terapije za zdravljenje parcialnih napadov, in enoletne odprte študije varnosti pri 54 pediatričnih bolnikih z epilepsijo, starih od 3 mesecev do 16 let, kažejo, da so opazili neželene učinke - pireksijo in okužbe zgornjih dihalpogosteje kot v študijah pri odraslih z epilepsijo (glejte poglavja 4.2, 4.8 in 5.2).
100 x 1 hard capsules in PVC/Aluminium perforated unit dose blisters. 
100 x 1 trda kapsula v PVC/aluminijskem perforiranem enoodmernem pretisnem omotu.
When taken with certain other medicines which have sedative effects (including opioids), Lyrica may potentiate these effects, and could lead to respiratory failure, coma and death. 
Kadar ga vzamemo z določenimi drugimi zdravili, ki imajo sedativni učinek (vključno z opioidi), lahko zdravilo Lyrica stopnjuje te učinke, kar lahko vodi do zmanjšanega delovanja dihal, kome in smrti.
For twice a day take Lyrica once in the morning and once in the evening, at about the same time each day. 
Če jemljete zdravilo Lyrica dvakrat na dan, ga vzemite enkrat zjutraj in enkrat zvečer, in sicer vsak dan ob približno istem času.
Remove the filled syringe from the bottle in the upright position (Figures 5 and 6). 
Odstranite napolnjeno brizgo s plastenke v navpičnem položaju (Sliki 5 in 6).
• The dose, which has been adjusted for you and your condition, will generally be between 150 mg (7.5 ml) and 600 mg (30 ml) each day. 
• Odmerek, prilagojen vam in vaši bolezni, bo praviloma med 150 mg (7,5 ml) in 600 mg (30 ml) na dan.
Pregabalin has been studied in 6 controlled trials of 4-6 week duration, an elderly study of 8 week duration and a long-term relapse prevention study with a double-blind relapse prevention phase of 6 months duration. 
Pregabalin so raziskovali v 6 nadzorovanih preskušanjih, ki so trajala od 4 do 6 tednov, v študiji starejših bolnikov, ki je trajala 8 tednov, ter v dolgoročni študiji preprečevanja recidiva s 6-mesečno dvojno slepo fazo preprečevanja recidiva.
Discharge the syringe contents into the mouth (Figure 7). 
Izpraznite vsebino brizge v usta (Slika 7).
There have been reports in the postmarketing experience of hypersensitivity reactions, including cases of angioedema. 
V obdobju trženja so poročali o preobčutljivostnih reakcijah, vključno z angioedemom.
473 ml oral solution 
473 ml peroralne raztopine
Epilepsy: Lyrica is used to treat a certain form of epilepsy (partial seizures with or without secondary generalisation-epileptic fits starting on one specific part of the brain) in adults. 
Epilepsija: Zdravilo Lyrica se uporablja za zdravljenje določene oblike epilepsije (parcialnih napadov s sekundarno generalizacijo ali brez nje - epileptični napadi se začenajo na določenem delu možgan) pri odraslih.
If you stop taking Lyrica 
Če ste prenehali jemati zdravilo Lyrica
Total pregabalin daily dose* Dose regimen 
celotni dnevni odmerek pregabalina*
If you forget to take Lyrica 
Če ste pozabili vzeti zdravilo Lyrica
This increased risk was observed at low doses of pregabalin (≤ 300 mg, aOR 1.52 [95% CI, 1.04 - 2.22]) and there was a trend for a greater risk at high doses of pregabalin (> 300 mg, aOR 2.51 [95% CI 1.24 - 5.06]). 
Povečano tveganje so opazili pri nizkih odmerkih pregabalina (≤ 300 mg, aOR 1,52 [95% IZ, 1,04 - 2,22]), opazili so tudi trend za povečano tveganje ob višjih odmerkih pregabalina (> 300 mg, aOR 2,51 [95% IZ 1,24 - 5,06]).
• There have been reports of heart failure in some patients when taking Lyrica; these patients were mostly elderly with cardiovascular conditions. 
• Pri nekaterih bolnikih, ki so jemali zdravilo Lyrica, so opisani primeri srčnega popuščanja; večinoma je šlo za starejše bolnike s srčnožilnimi boleznimi.
Rinse the syringe by drawing water into the syringe and pushing the syringe plunger to the bottom of the syringe barrel, at least three times (Figure 8). 
Izperite brizgo, tako da v brizgo potegnete vodo in pritisnete bat brizge do njenega dna, postopek ponovite vsaj trikrat (Slika 8).
Caution is advised when prescribing pregabalin concomitantly with opioids due to risk of CNS depression (see section 4.5). 
Pri predpisovanju pregabalina sočasno z opioidi je potrebna previdnost zaradi tveganja za pojav depresije osrednjega živčevja (glejte poglavje 4.5).
• When Lyrica is taken with other medicines that may cause constipation (such as some types of pain medicines) it is possible that gastrointestinal problems may occur (e.g. constipation, blocked or paralysed bowel). 
• Ob sočasni uporabi zdravila Lyrica z ostalimi zdravili, ki lahko povzročijo zaprtost (kot so nekatera zdravila proti bolečinam), obstaja možnost pojava prebavnih težav (npr. zaprtje, zaprto ali paralizirano črevo).
Each ml contains 1.3 mg of methyl parahydroxybenzoate (E218), 0.163 mg of propyl parahydroxybenzoate (E216) 
1 ml vsebuje 1,3 mg metilparahidroksibenzoata (E218) in 0,163 mg propilparahidroksibenzoata (E216).
What Lyrica looks like and contents of the pack 25 mg capsules 
Izgled zdravila Lyrica in vsebina pakiranja 25 mg kapsule
If the PIBA is not already in place, remove the PIBA and 5 ml oral syringe from the plastic overwrap. 
Če nastavek za peroralno brizgo še ni nameščen, vzemite nastavek in 5-ml peroralno brizgo iz plastične folije.